USBoard
Person

Jonathan T. Lord MD

Formerly Director, Dexcom

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$1.8M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • DXCM
    Dexcom
    Director
    May 2016 – last filing Sep 2016

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Sep 1, 2016DXCMSale10,000$91.50$915K
Aug 12, 2016DXCMSale5,000$90.50$453K
Aug 11, 2016DXCMSale5,000$90.78$454K

SEC reporting-owner ID (CIK) 1112980 · all filings on EDGAR